multipl
sclerosi
ms
neuroinflammatori
demyelin
diseas
affect
million
individu
worldwid
macrophag
lymphocyt
infiltr
central
nervou
system
cn
along
resid
microglia
releas
proinflammatori
cytokin
culmin
oligodendrocyt
damag
death
result
multifoc
white
matter
demyelin
lesion
caus
dampen
saltatori
signal
transduct
axon
ultim
lead
varieti
insidi
clinic
symptom
includ
motor
cognit
behavior
defici
numb
pain
extrem
loss
vision
dementia
symptom
may
manifest
episod
separ
function
recoveri
term
relapsingremit
ms
may
continu
progress
increas
debil
term
progress
ms
believ
remyelin
reduc
neuroinflamm
adapt
cn
respons
respons
remit
phase
diseas
therefor
attempt
prolong
remiss
prevent
new
lesion
format
diseasemodifi
therapi
focu
reduc
leukocyt
traffick
prolifer
cn
howev
fdaapprov
therapeut
indic
relapsingremit
ms
ms
patient
diagnos
progress
ms
onset
term
primaryprogress
ms
patient
develop
progress
ms
within
year
diagnosi
secondari
progress
treatment
progress
ms
long
sought
yet
remain
elus
histor
focu
neuroinflamm
demyelin
ms
may
delay
develop
effect
treatment
progress
ms
irrevers
axon
damag
neurodegener
identifi
caus
factor
chronic
function
disabl
progress
diseas
inde
patient
progress
form
ms
increas
cn
atrophi
spinal
cord
cerebellum
cerebr
cortex
attribut
axon
loss
progress
patient
also
like
decreas
level
nacetyl
aspart
within
brain
indic
precipit
drop
neuron
correspond
evid
shown
increas
neuron
apoptosi
morpholog
indic
axon
patholog
ovoid
swell
thin
transect
found
cn
biopsi
ms
patient
also
evid
neurodegen
diseas
furthermor
intern
structur
chang
found
immunohistochemistri
monoclon
antibodi
recogn
nonphosphoryl
neurofila
found
damag
axon
accumul
amyloid
precursor
protein
app
found
damag
axon
due
transport
defici
app
posit
axon
found
demyelin
lesion
postmortem
ms
biopsi
importantli
loss
neuron
progress
ms
attribut
axon
degener
causat
ms
axonopathi
contest
inflammatori
demyelin
lesion
identifi
patient
magnet
reson
imag
mri
postmortem
cn
biopsi
luxol
fast
blue
lfb
stain
histor
axon
loss
consid
result
demyelin
outsideinmodel
axon
degener
demyelin
diseas
figur
recent
axon
loss
also
found
nonlesion
white
matter
postmortem
ms
biopsi
identifi
mri
lfb
term
normal
appear
white
matter
nawm
indic
axon
damag
absenc
inflamm
demyelin
form
axon
damag
refer
wallerian
degener
insideoutmodel
axon
degener
myelin
sheath
appear
empti
tube
due
axon
loss
within
myelin
sheath
figur
rel
import
two
model
signific
understand
optim
treatment
strategi
axon
neurodegener
target
treatment
prevent
demyelin
suffici
save
axon
neuron
mani
factor
contribut
axon
degener
complic
abil
confirm
whether
demyelin
axonopathi
occur
first
lack
physic
trophic
support
myelin
sheath
may
contribut
axon
loss
howev
axon
damag
alway
secondari
demyelin
axonopathi
also
attribut
attack
inflammatori
cell
secret
inflammatori
cytokin
toxic
speci
increas
macrophag
microglia
densiti
within
cn
microenviron
attribut
axon
loss
investig
show
microglia
contact
surround
axon
dendrit
cortic
lesion
microglia
encapsul
transect
end
axon
white
matter
lesion
impli
direct
involv
degener
axon
addit
cell
densiti
also
correl
axon
damag
ms
patient
biopsi
myeloid
cell
may
also
caus
axon
damag
releas
neurodegen
molecul
glutam
reactiv
oxygen
speci
ro
reactiv
nitrogen
speci
rn
furthermor
astrocyt
oligodendrocyt
decreas
express
glutam
clearanc
metabol
receptor
ms
lesion
result
increas
glutam
detect
cerebrospin
fluid
ms
patient
within
tumefact
demyelin
lesion
increas
glutam
receptor
neuron
increas
vulner
excitotox
degener
ro
rn
glutam
may
also
travers
myelin
sheath
diffus
node
ranvier
degener
axon
highlight
one
possibl
caus
wallerian
degener
myelin
axon
activ
neuron
glutam
receptor
glutam
rn
upregul
extracellular
ro
rn
releas
intracellular
increas
intracellular
activ
neurofila
fragment
proteas
may
caus
transport
defici
seen
degener
axon
intracellular
na
also
increas
due
increas
axon
na
channel
neuron
adapt
respons
demyelin
due
increas
import
na
exchang
expel
excess
intracellular
result
nakatpas
activ
rise
expel
excess
na
caus
deplet
atp
energi
defici
exacerb
mitochondri
function
impair
caus
ro
rn
well
insuffici
mitochondria
along
length
axon
due
previous
mention
axon
transport
defici
therefor
ro
rn
glutam
caus
impair
neurofila
integr
mitochondria
densiti
function
energi
metabol
atp
synthesi
axon
case
biolog
system
larg
number
factor
play
role
axon
degener
vari
relationship
feedback
loop
redund
inflamm
caus
demyelin
demyelin
caus
axonopathi
inflamm
caus
axonopathi
demyelin
enhanc
inflamm
interconnect
relationship
increas
difficulti
find
singl
therapeut
target
progress
ms
histopatholog
confoc
imag
molecular
biolog
techniqu
yield
insight
relationship
howev
definit
understand
axon
degener
ms
still
lack
mechan
result
neurodegener
complex
dynam
axon
damag
caus
inflammatori
cell
attack
inflammatori
cytokin
excitotox
molecul
myelin
damag
process
also
involv
flux
molecular
ion
concentr
morpholog
chang
intern
structur
organel
damag
electr
conduct
dysfunct
highli
dynam
multivari
natur
axon
degener
make
wellsuit
beneficiari
realtim
imag
last
halfdecad
converg
microscopi
preclin
murin
ms
model
variou
transgen
anim
dye
allow
realtim
visual
axon
degener
respect
morpholog
chang
organel
transport
damag
inflamm
axon
health
neuron
excitotox
regen
therapeut
thu
far
microscopi
use
studi
axon
degener
follow
infect
mice
neurotrop
jhm
strain
mous
hepat
viru
jhmv
induct
experiment
autoimmun
encephalomyel
eae
model
independ
uniqu
one
anoth
share
import
histolog
featur
ms
includ
neuroinflamm
demyelin
neurodegener
eae
commonli
use
preclin
murin
model
ms
research
discov
inject
emulsifi
cn
tissu
transfer
lymph
node
cell
anim
sensit
cn
tissu
induc
encephalomyel
varieti
anim
host
today
activ
eae
initi
inject
defin
encephalitogen
myelin
protein
epitop
combin
complet
freund
adjuv
cfa
wherea
passiv
eae
induc
transfer
encephalitogen
myelinsensit
lymphocyt
eae
model
also
requir
administr
microbialbas
immunolog
adjuv
pertussi
toxin
pt
thought
enhanc
eae
induct
increas
barrier
bbb
permeabl
expand
myeloid
cell
antigenspecif
lymphocyt
reduc
regulatori
lymphocyt
modul
express
inflammatori
cytokin
pt
often
administ
donor
mice
passiv
eae
activ
eae
mice
depend
murin
strain
immun
antigen
like
ms
eae
clinic
cours
highli
variabl
research
achiev
intend
mslike
clinic
cours
base
murin
strain
inject
antigen
adjuv
activ
eae
studi
axonopathi
induc
inject
mice
myelin
oligodendrocyt
glycoprotein
mog
peptid
fragment
conjunct
cfa
stimul
robust
cell
respons
studi
pt
inject
day
postimmun
result
neuroinflamm
diseas
induct
axon
densiti
immun
mice
significantli
decreas
lesion
nawm
gray
matter
diseas
onset
measur
bielschowski
silver
impregn
app
posit
axon
found
prior
diseas
onset
demyelin
interestingli
cell
infiltr
low
point
rather
astrocyt
hypertrophi
wide
observ
concomit
axon
injuri
data
demonstr
axon
damag
may
preced
detect
demyelin
eae
number
viral
pathogen
implic
human
ms
includ
viru
ebv
human
differenti
preval
ms
geograph
locat
increas
risk
individu
reloc
high
preval
geographi
may
attribut
viral
infect
therefor
preclin
viral
model
ms
import
tool
understand
diseas
pathogenesi
test
potenti
therapeut
mechan
jhmv
positivesens
singlestrand
rna
viru
coronavirida
famili
intracrani
inject
jhmv
mice
result
acut
encephalomyel
chronic
inflammatori
demyelin
axonopathi
cn
jhmv
infect
replic
within
oligodendrocyt
astrocyt
microglia
demyelin
occur
due
lymphocytedirect
respons
viral
antigen
macrophagemedi
strip
myelin
virusinduc
apoptosisnecrosi
oligodendroglia
clinic
symptom
includ
ataxia
lower
limb
paralysi
start
week
infect
peak
week
later
peak
diseas
lowlevel
inflamm
demyelin
lesion
present
like
due
viral
persist
level
detect
studi
use
immunodefici
mice
lack
function
b
lymphocyt
indic
lymphocyt
well
macrophag
key
contributor
demyelin
jhmvinfect
mice
howev
jhmvinfect
mice
exhibit
signific
increas
immunolabel
comparison
mice
despit
lack
demyelin
reactiv
coincid
area
macrophag
microgli
infiltr
activ
signific
increas
immunolabel
jhmvinfect
mice
receiv
splenocyt
jhmvimmun
wildtyp
mice
though
statist
differ
adopt
transfer
splenocyt
deplet
cell
data
suggest
demyelin
necessari
axon
damag
occur
jhmvinfect
mice
damag
may
mediat
factor
travers
myelin
sheath
cell
inflamm
demyelin
significantli
exacerb
axon
damag
thu
insideout
outsidein
model
axon
degener
perpetu
jhmv
accord
studi
local
administr
glutam
nitric
oxid
donor
induc
axonopathi
mice
also
use
understand
mechan
axon
degener
regener
context
demyelin
diseas
thu
autoimmun
viral
excitoxicityinduc
model
provid
clue
axon
damag
may
preced
demyelin
howev
understand
realtim
interact
visual
causeandeffect
fulli
realiz
static
snapshot
histopatholog
flow
cytometri
molecular
biolog
techniqu
provid
import
data
regard
axon
biolog
cn
demyelin
diseas
larg
focus
marker
axon
damag
presenc
variou
inflammatori
cell
glia
along
other
employ
imag
better
understand
dynam
chang
axon
morpholog
patholog
model
neuroinflamm
excitotox
cell
replac
therapi
confoc
microscopi
singl
photon
excit
fluoresc
molecul
higher
energi
state
imag
two
lower
energi
photon
simultan
excit
fluoresc
molecul
higher
energi
state
order
achiev
high
enough
photon
densiti
simultan
absorpt
spatial
tempor
restrict
impos
high
power
laser
focus
puls
peak
puls
enough
energi
creat
excit
order
creat
imag
focus
laser
scan
target
tissu
spatial
photon
densiti
drop
rapidli
focu
prevent
outoffocu
excit
ultim
prevent
background
photobleach
surround
area
therefor
background
signal
significantli
decreas
microscopi
compar
onephoton
confoc
microscopi
furthermor
longer
excit
wavelength
result
decreas
scatter
autofluoresc
phototox
due
decreas
scatter
microscopi
ideal
allow
imag
mm
depth
confoc
microscopi
limit
result
technolog
may
util
visual
thicker
tissu
section
tissu
vivo
whole
organ
situ
therefor
imag
provid
abil
monitor
cellular
molecular
movement
veloc
locat
interact
within
endogen
cn
microscopi
use
imag
axon
brainstem
dorsal
spinal
cord
ventral
spinal
cord
murin
ms
model
brainstem
dorsal
spinal
cord
may
access
vivo
due
limit
imag
depth
necessari
extract
spinal
cord
imag
situ
captur
dynam
ventral
region
therefor
order
captur
exogen
engraft
gfpexpress
neural
precursor
cell
npc
dynam
ventral
spinal
cord
greenberg
et
al
develop
novel
techniqu
extract
imag
spinal
cord
situ
sacrific
omit
cervic
disloc
full
laminectomi
perform
cervic
vertebra
lumbar
spinal
column
spinal
cord
care
resect
necessari
level
remov
spinal
cord
embed
agaros
maintain
stabil
imag
perfus
warm
oxygen
media
standard
setup
vivo
imag
brainstem
spinal
cord
involv
anesthet
mainten
bodi
temperatur
tracheotomi
intub
mainten
respir
circul
salin
solut
mous
artifici
cerebrospin
fluid
expos
imag
site
order
expos
brainstem
necessari
inclin
head
enhanc
imag
depth
remov
musculatur
dura
mater
cervic
vertebra
base
skull
steril
agaros
patch
must
kept
dampen
breath
heartbeat
artifact
techniqu
allow
visual
dorsal
medulla
oblongata
caudal
cerebellum
upper
spinal
cord
adapt
gobel
helmchen
order
visual
dorsal
spinal
cord
necessari
perform
laminectomi
remov
dura
mater
appropri
spinal
cord
level
techniqu
first
describ
kerschenstein
et
al
transgen
murin
line
facilit
use
studi
axon
degener
preclin
ms
model
morpholog
locat
motil
concentr
interact
endogen
label
cell
organel
andor
variou
molecul
monitor
differ
diseas
state
one
wide
use
transgen
anim
line
studi
axonopathi
preclin
ms
model
mous
mice
express
spectral
variant
gfp
within
cytoplasm
subset
neuron
axonopathi
eae
jhmv
commonli
studi
brainstem
spinal
cord
mice
larg
number
mediumtolarg
calib
axon
fluoresc
yfp
gfp
respect
mice
use
lesser
extent
due
sparser
axon
fluoresc
mice
cross
mice
visual
lymphocyt
macrophagesmicroglia
respect
interact
axon
activ
eae
mice
also
cross
mice
order
visual
mitochondria
peroxisom
respect
within
axon
mice
develop
investig
axon
transport
chang
occur
degener
microtubul
maintain
axon
structur
direct
transport
within
axon
endbind
protein
one
three
microtubul
plusend
track
protein
facilit
microtubul
growth
grow
end
express
yfp
subset
axon
mice
fluoresc
resembl
comet
speed
direct
orient
length
cometlik
structur
monitor
indic
microtubul
outgrowth
chang
patholog
recent
reson
energi
transfer
fret
base
genet
encod
sensor
geci
use
measur
within
neuron
patholog
preclin
ms
model
transgen
mice
express
troponin
c
bound
cfp
one
end
yfp
troponin
c
bind
protein
exhibit
expand
conform
baselin
level
intracellular
state
excit
absorb
wavelength
cfp
result
cfp
emiss
upon
increas
intracellular
troponin
c
bind
contract
bring
cfp
yfp
closer
excit
cfp
absorb
wavelength
energi
transfer
cfp
yfp
due
proxim
yfp
signal
emit
thu
chang
axon
monitor
calcul
ratio
cfp
yfp
varieti
techniqu
enabl
visual
cellular
molecular
activ
murin
ms
model
asid
use
transgen
anim
tissu
stain
vivo
fluoresc
cell
transplant
transgen
anim
cell
label
vitro
subsequ
transplant
former
two
techniqu
util
studi
axon
patholog
murin
ms
model
romanelli
et
al
publish
protocol
stain
spinal
cord
tissu
vivo
imag
protocol
use
label
myelin
use
fluoromyelin
stain
invitrogen
cell
trace
bodipi
tr
methyl
ester
dye
invitrogen
nile
red
stain
inflammatori
cellular
infiltr
anim
vital
dye
also
use
imag
visual
realtim
chang
relev
molecular
concentr
signal
hydrogen
peroxid
ro
measur
amplex
ultrar
reagent
invitrogen
nitric
oxid
rn
measur
daffm
diacet
reagent
invitrogen
mitochondri
membran
potenti
measur
tetramethylrhodhamin
tmrm
methyl
ester
invitrogen
siffrin
et
al
creat
bone
marrow
chimer
mice
order
visual
activ
rfpexpress
bone
marrowderiv
peripher
immun
cell
tdrfp
anim
eae
induc
group
also
initi
eae
mice
inject
vitro
differenti
tcr
transgen
cell
tdrfp
mice
helper
cell
isol
total
splenocyt
use
magnet
bead
cell
sort
cell
stimul
mog
peptid
cytokin
induc
specif
differenti
cell
cell
also
transplant
anim
follow
induct
eae
via
inject
nonfluoresc
cell
allow
visual
rfpexpress
cell
relat
egfp
axon
ovalbuminspecif
tcr
transgen
cell
deriv
similar
manner
vitro
also
visual
transplant
nonfluoresc
eae
anim
result
possibl
monitor
dynam
interact
cell
vari
differenti
statu
specif
relat
eaeinduc
axonopathi
laboratori
use
npc
deriv
gfp
mice
cell
express
gfp
constitut
control
proteolipid
protein
plp
promot
respect
use
microscopi
monitor
live
interact
verifi
previou
histolog
evid
npc
differenti
upon
interact
damag
axon
jhmvinfect
mice
thu
larg
varieti
experi
conduct
select
transgen
mous
line
combin
imag
addit
vital
dye
requir
time
expens
anim
care
number
variabl
simultan
monitor
dramat
expand
technic
limit
must
consid
use
microscopi
photobleach
must
mitig
use
low
laser
power
compensatori
equat
monoexponenti
decay
adjust
util
normal
phenomenon
varianc
scatter
differ
fluorophor
may
give
fals
impress
rel
emiss
intens
depth
ratiometr
signal
construct
use
geci
may
affect
sinc
cfp
scatter
yfp
yfpcfp
ratio
axon
within
brainstem
mice
increas
depth
give
fals
impress
slight
increas
linear
correct
may
use
compens
differenti
scatter
consid
depth
limit
microscopi
altern
method
may
aid
gain
complet
understand
patholog
cn
mri
may
util
identifi
deep
lesion
inflamm
axon
damag
demyelin
live
mice
follow
lesion
identif
may
possibl
take
tissu
section
deep
lesion
visual
live
cellular
molecular
dynam
situ
use
microscopi
altern
varieti
techniqu
develop
order
make
tissu
section
whole
organ
transpar
transparent
reduc
scatter
allow
greater
imag
depth
confoc
microscopi
howev
process
requir
fixat
thu
use
visual
static
snapshot
patholog
vital
dye
may
exhibit
nonspecif
bind
compartment
leakag
therefor
necessari
minim
variat
prepar
dye
locat
dye
administr
dye
incub
time
imag
durat
locat
imag
transgen
anim
line
may
seem
superior
consider
limit
addit
data
easili
gain
dye
make
irreplac
boon
live
imag
current
time
given
varieti
advanc
techniqu
visual
cell
organel
variou
molecul
one
must
consid
limit
pose
overlap
emiss
spectra
gener
limit
number
channel
detect
time
furthermor
mani
transgen
variant
vital
dye
made
emiss
spectra
often
gfp
rfp
lesser
extent
yfp
cfp
use
must
enough
varieti
variabl
experi
differ
emiss
spectrum
use
timelaps
imag
look
axon
mice
eae
jhmv
model
novel
tempor
connect
made
axon
swell
ovoid
transect
thin
describ
ms
neurodegen
diseas
nikic
et
al
describ
revers
progress
stage
axon
patholog
observ
microscopi
eae
mice
postonset
term
focal
axon
degener
fad
fad
consist
three
stage
stage
normal
appear
axon
stage
axon
focal
swell
stage
axon
transect
axon
patholog
progress
revers
stage
stage
axon
may
progress
stage
regress
stage
importantli
stage
axon
observ
revert
back
stage
use
approach
observ
fad
also
occur
jhmvinfect
mice
earli
follow
cn
infect
figur
upon
immunolabel
detect
addit
nuanc
fad
patholog
previous
describ
axon
could
combin
andor
section
mean
part
axon
could
consid
healthi
intact
intact
damag
transect
figur
detect
axon
indic
yfp
loss
may
suffici
indic
complet
transect
subsequ
immunolabel
detect
healthi
phosphoryl
neurofila
show
immunoreact
exclus
yfp
axon
data
also
contribut
histor
import
question
regard
axon
degener
demyelin
diseas
three
stage
detect
myelin
axon
provid
traction
insideout
model
axon
degener
fad
axon
found
fulli
myelin
axon
though
partial
fulli
demyelin
stage
stage
axon
corrobor
previou
ms
data
axon
degener
occur
myelin
axon
preval
demyelin
axon
inflamm
ubiquit
link
axon
degener
use
timelaps
imag
nikic
et
al
also
found
stage
axon
like
degener
stage
axon
peak
clinic
symptom
elev
inflamm
recoveri
like
even
day
peak
symptom
use
imag
complement
standard
laboratori
techniqu
transgen
anim
understand
tempor
characterist
axon
degener
demyelin
diseas
corrobor
advanc
morpholog
chang
axon
accompani
organel
damag
transport
defici
though
normal
undetect
immunolabel
app
detect
accumul
due
defect
axon
transport
found
acut
lesion
border
activ
chronic
ms
lesion
imag
spinal
cord
eae
mice
show
fad
axon
signific
increas
comet
orient
retrograd
direct
compar
fad
axon
axon
control
mice
microtubul
orient
also
highli
variant
often
parallel
axon
howev
upon
induct
eae
axon
exhibit
comet
orient
variou
angl
order
continu
understand
transport
defici
sorbara
et
al
visual
axon
mitochondria
peroxisom
microscopi
allow
visual
quantif
veloc
direction
locat
stop
durat
concord
data
anterograd
retrograd
mitochondri
flux
significantli
decreas
axon
furthermor
mitochondri
peroxisom
flux
significantli
decreas
fad
eae
axon
compar
control
axon
indic
transport
deficit
may
occur
morpholog
chang
axon
mitochondri
speed
significantli
decreas
stop
durat
significantli
increas
frequenc
stop
significantli
increas
anterograd
direct
eae
axon
result
mitochondri
transport
deficit
signific
reduct
seen
organel
densiti
distal
portion
axon
match
increas
retrogradeori
lack
organel
mitochondria
throughout
length
axon
may
signific
impact
maintain
neuron
homeostasi
health
track
mitochondria
monitor
transport
defici
ms
model
highli
use
consid
also
identifi
earli
marker
axon
patholog
cortic
biopsi
ms
patient
shown
decreas
mrna
express
impair
activ
mitochondri
electron
transport
chain
complex
effect
may
correl
inflamm
decreas
axon
mitochondria
complex
iv
activ
associ
increas
local
macrophagemicrogli
densiti
find
corrobor
complex
interact
inflamm
axon
health
mitochondri
health
densiti
defici
transport
mitochondria
throughout
axon
complement
mitochondri
structur
function
chang
parallel
evid
mitochondria
transport
deficit
occur
normal
fad
axon
mitochondri
dysfunct
dysmorphia
preced
morpholog
chang
axon
electron
microscopi
reveal
swollen
round
mitochondria
within
fad
axon
eaeinduc
mice
given
inform
eae
induc
mice
visual
mitochondri
morpholog
membran
potenti
imag
quantif
factor
reveal
decreas
shape
factor
indic
dysmorphia
correl
abnorm
low
mitochondri
membran
potenti
dysmorph
mitochondria
found
either
control
anim
immun
anim
prior
diseas
onset
swollen
mitochondria
found
fad
axon
locat
within
inflammatori
lesion
concord
previou
histolog
ms
data
axon
mitochondria
damag
local
area
increas
macrophag
microgli
inflamm
perhap
due
releas
ro
rn
reactiv
oxygen
speci
rn
significantli
increas
lesion
eae
mice
upon
onset
applic
speci
healthi
mice
spinal
cord
show
result
mitochondri
fad
chang
similar
occur
eae
without
demyelin
examin
activ
lesion
ms
biopsi
show
mitochondri
damag
regardless
demyelin
state
similar
data
show
fulli
myelin
fad
axon
therefor
imag
provid
signific
evid
axon
damag
relat
transport
mitochondri
defici
occur
area
inflamm
releas
ro
rn
speci
macrophag
microglia
may
one
contributor
axon
damag
inflammatori
cell
found
contact
axon
caus
degener
demyelin
diseas
reactiv
axon
found
area
high
macrophag
microgli
densiti
jhmv
spinal
cord
ms
app
reactiv
axon
increas
correl
manner
lymphocyt
macrophagemicroglia
densiti
lesion
periplaqu
white
matter
furthermor
pattern
axon
transect
activ
chronic
activ
lesion
match
mhc
class
iiposit
macrophag
microglia
apposit
contact
engulf
axon
dendrit
soma
microglia
detect
ms
activ
chronic
activ
cortic
lesion
correl
axon
damag
transect
use
microscopi
nikic
et
al
also
found
increas
macrophag
microgli
densiti
local
axon
acut
eae
lesion
mice
siffrin
et
al
use
microscopi
brainstem
eae
mice
understand
motil
characterist
cell
implic
caus
clinic
histolog
diseas
upon
induct
eae
cell
activ
eae
bone
marrow
chimera
tdrfp
mice
adopt
transfer
vitro
differenti
cell
passiv
induct
eae
mice
show
high
motil
invas
parenchyma
howev
cell
show
decreas
veloc
peak
chronic
diseas
cell
maintain
veloc
diseas
stage
except
remiss
decreas
veloc
associ
decreas
displac
rate
increas
meander
diseas
corrobor
notion
antigenspecif
cell
stop
upon
recognit
cognat
antigen
present
mhc
molecul
previous
shown
eae
consequ
siffrin
et
al
induc
passiv
eae
mice
adopt
transfer
nonfluoresc
cell
visual
effect
differenti
statu
antigenspecif
interact
behavior
studi
compar
enrich
cell
three
cell
type
higher
mean
veloc
displac
rate
cell
analysi
show
cell
increasingli
scan
dysmorph
axon
lesion
contact
neuron
frequent
longer
particularli
peak
diseas
hand
cell
seem
undergo
motil
chang
akin
antigen
recognit
rather
engag
random
nonspecif
abbrevi
contact
howev
data
also
indic
contact
antigen
independ
cell
engag
neuron
interact
use
electron
microscopi
vitro
cocultur
immunocytochemistri
character
interact
siffrin
et
al
found
contact
lymphocyt
variou
myelin
unmyelin
region
neuron
point
contact
lymphocyt
exhibit
polar
organel
microtubuleorgan
center
similar
immun
synaps
contact
found
mhc
class
ii
antigen
independ
depend
adhes
molecul
cluster
immun
synaps
contact
site
target
cytolyt
granul
cell
surfac
cell
caus
neuron
death
cocultur
cell
supernat
data
impli
cell
make
immun
synapselik
contact
neuron
especi
peak
diseas
potenti
caus
neuron
degener
death
discoveri
remark
interact
highli
depend
abil
visual
interact
real
time
sustain
contact
eae
correl
intracellular
increas
earli
sign
axon
patholog
increas
axon
seen
upon
cell
contact
decreas
upon
separ
mogeaeinduc
bone
marrow
chimer
mice
anim
induc
passiv
eae
adopt
transfer
cell
induc
activ
mogea
show
local
increas
within
contact
neuron
process
soma
eae
lesion
highest
increas
model
found
border
activ
demyelin
lesion
high
amount
disintegr
myelin
debri
sustain
contact
result
achiev
critic
signal
preced
axon
dissect
contact
site
irrevers
damag
soma
quantifi
gfp
voxel
indic
neurodegener
decreas
neuron
tissu
found
presenc
cell
increas
app
immunolabel
corrobor
result
inde
caus
progress
diseas
decreas
remiss
increas
mortal
compar
cell
interestingli
inject
ovalbuminspecif
cell
result
reduc
elev
axon
though
veloc
contact
dynam
found
antigen
specif
axon
chang
may
glutam
excitotox
also
caus
increas
axon
inhibit
nmda
glutam
receptor
eae
shown
decreas
neurolog
symptom
inflammatori
cytokin
product
imag
show
local
administr
glutam
brainstem
mice
result
local
axon
increas
well
morpholog
chang
swell
transect
data
indic
varieti
chang
occur
axon
preclin
ms
model
wide
array
potenti
therapeut
target
includ
glutam
excitotox
morpholog
chang
ion
concentr
chang
inflammatori
cell
contact
drugsmolecular
therapeut
npc
investig
potenti
allevi
axon
patholog
ms
model
molecular
therapeut
test
fdaapprov
ms
drug
biolog
byproduct
axon
channelreceptor
blocker
rosrn
scaveng
therapeut
effect
axon
patholog
monitor
microscopi
summar
tabl
allur
stem
cell
lie
abil
differenti
replac
lost
tissu
well
releas
regen
factor
therapeut
potenti
neural
stem
cell
nsc
npc
investig
demyelin
diseas
especi
regard
abil
myelin
axon
numer
transplant
studi
demyelin
model
eae
shiver
mice
genet
model
dysmyelin
shown
nscnpcbase
therapi
decreas
inflamm
increas
number
myelin
cell
cn
therapi
includ
bone
marrow
mesenchym
stem
cellderiv
nsc
oligodendrocyt
progenitor
cell
human
cn
nsc
transplant
allogen
human
cn
stem
cell
frontal
lobe
human
patient
earli
onset
diseas
congenit
dysmyelin
diseas
indic
procedur
safe
well
toler
also
result
myelin
result
promis
requir
investig
understand
mechan
action
microscopi
wellsuit
techniqu
monitor
dynam
interact
therapeut
cell
damag
axon
anim
model
electron
microscopi
immunohistochemistri
impli
syngen
murin
npc
transplant
jhmvinfect
mice
remyelin
axon
imag
mice
confirm
initi
observ
transplant
preferenti
local
axon
increas
fad
engraft
confirm
npc
matur
myelinproduc
oligodendrocyt
remyelin
axon
immunostain
transvers
spinal
cord
section
transplant
jhmvinfect
mice
myelin
basic
protein
mbp
anoth
compon
myelin
show
cell
inde
produc
myelin
microscopi
allow
live
visual
spatial
juxtaposit
therapeut
npc
axon
first
time
summari
cellular
molecular
compon
axonopathi
imag
microscopi
preclin
ms
model
found
figur
perspect
microscopi
current
highest
resolut
methodolog
live
imag
normal
diseas
cn
tissu
number
advanc
make
technolog
access
imag
axonopathi
develop
cn
imag
setup
transgen
anim
visual
axon
cn
variou
chemic
dye
visual
structur
thu
far
microscopi
facilit
signific
gain
understand
axon
degener
murin
ms
model
eae
known
depend
time
use
transgen
report
mice
uniqu
novel
connect
made
cell
fad
irrevers
neuron
damag
similarli
morpholog
damag
axon
detect
stain
neurofila
bielschowski
silver
impregn
discoveri
tempor
progress
morpholog
damag
made
possibl
timelaps
imag
despit
signific
progress
whether
demyelin
axon
damag
occur
first
suffici
answer
data
show
structur
degener
mitochondri
impair
ion
concentr
imbal
may
start
occur
demyelin
howev
axon
patholog
product
inflamm
demyelin
fdaapprov
diseasemodifi
therapi
corticosteroid
believ
reduc
neuroinflamm
believ
prevent
onset
progress
diseas
therefor
may
possibl
altern
mechan
caus
axon
damag
current
therapeut
suffici
decreas
neuroinflamm
data
increasingli
suggest
veriti
insideout
model
possibl
axon
damag
demyelin
independ
event
caus
may
continu
studi
phenomena
necessari
develop
potenti
therapi
research
requir
answer
follow
question
axon
damag
ms
axonopathi
demyelin
occur
first
singletarget
therapeut
suffici
allevi
axonopathi
nscsnpc
provid
longterm
treatment
demyelin
diseas
imag
provid
signific
gain
move
closer
answer
question
thu
far
relationship
ro
rn
glutam
inflamm
axon
patholog
morpholog
damag
transport
deficit
mitochondri
defici
excitotox
investig
use
import
area
studi
futur
mechan
demyelin
onset
viral
model
caus
effect
glutam
excitotox
loss
trophic
support
glia
downstream
neuron
mani
ultim
better
understand
complex
relationship
occur
neuroinflammatori
demyelin
may
stumbl
upon
singl
point
convalesc
one
challeng
develop
therapeut
ms
lack
understand
pathogenesi
togeth
preclin
murin
model
microscopi
provid
methodolog
understand
onset
demyelin
axonopathi
thu
microscopi
may
facilit
gain
mechanist
understand
axon
damag
order
develop
therapeut
progress
ms
author
list
made
substanti
direct
intellectu
contribut
work
approv
public
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
